Variable | Patients n =114 | ||
---|---|---|---|
Group A BPS-NFRT n = 57 | Group B BPS n = 57 | P | |
Age | |||
Median * | 61.0 (54.0 – 72.0) | 68.0 (63.0 – 81.0) | <0.001 |
Sex, n (%) | |||
Male | 44 (77.2) | 37 (64.9) | 0.221 |
Female | 13 (22.8) | 20 (35.1) | 0.070 |
ICU – LOS | |||
Median * | 10.0 (5.0 – 19.0) | 10.0 (5.0 – 20.5) | 0.756 |
Mortality, n (%) | 6.0 (10.5) | 15.0 (26.3) | 0.029 |
Disease severity scoring | |||
SAPS II * | 36.0 (29.0 – 45.0) | 38.0 (32.0 – 47.0) | 0.374 |
TISS–28 * | 19.0 (14.0 – 24.0) | 18.0 (10.0 – 24.0) | 0.285 |
Analgesics and sedatives | |||
Sufentanil μg/h | |||
Median * | 12.5 (5.6 – 20.0) | 15.0 (5.0 – 20.0) | 0.388 |
n (%) | 8 (14.0) | 7 (12.3) | 0.68 |
Remifentanil mg/h | |||
Median * | 0.3 (0.2 – 0.4) | 0.2 (0.2 – 0.3) | <0.001 |
n (%) | 37 (64.9) | 37 (64.9) | 1.000 |
Metamizole mg/h | |||
Median * | 168.0 (168.0 – 168.0) | 168.0 (168.0 – 168.0) | 0.167 |
n (%) | 36 (63.2) | 39 (69.4) | 0.570 |
Propofol mg/h | |||
Median * | 200.0(140.0 – 200.0) | 200.0(100.0 – 280.0) | 1.000 |
n (%) | 41 (71.9) | 37 (64.9) | 0.462 |
Lormetazepam mg/h | |||
Median * | 0.6 (0.3 – 0.8) | 0.6 (0.5 – 0.8) | 0.801 |
n (%) | 12 (21.1) | 13 (22.8) | 0.74 |
Measurement of sedation depth and pain intensity | |||
Richmond Agitation Sedation Scale – Median * | |||
-4.0 (-5.0 – -3.0) | -3.0 (-4.0 – -2.0) | 0.001 | |
Behavioral Pain Scale | |||
Median * | 3.0 (3.0 – 3.0) | 3.0 (3.0 – 4.0) | 0.631 |
BPS 3 (n) | 51 | 56 | 0.875 |
BPS 4 (n) | 28 | 57 | <0.001 |
BPS 5 (n) | 6 | 4 | 0.38 |
BPS 6 (n) | 2 | 1 | n.e. |
BPS 7 (n) | 1 | 0 | n.e. |
BPS 8 (n) | 1 | 0 | n.e. |
BPS 9 (n) | 1 | 0 | n.e. |
Primary reason for ICU admission, n (%) | |||
Neurosurgery & brain hemorrhage | 13 (22.8) | 16 (28.1) | 0.37 |
Abdominal surgery | 15 (26.3) | 15 (26.3) | 1.00 |
Trauma surgery | 5 (8.8) | 6 (10.5) | 0.65 |
Cardiac surgery | 2 (3.5) | 1 (1.8) | ----------- |
Vascular surgery | 4 (7.0) | 8 (14.0) | 0.16 |
Thoracic surgery | 5 (8.8) | 3 (5.3) | 0.37 |
Respiratory failure | 5 (8.8) | 3 (5.3) | 0.37 |
Internal medicine | ----------- | 1 (1.8) | ----------- |
Urology | 7 (12.3) | 4 (7.7) | 0.24 |
Oral and maxillofacial surgery | 1 (1.8) | ----------- | ----------- |